Here, TGFβ–treated myotube secretome negatively affects myoblast differentiation and, more specifically, fusion, but SETDB1 LOF in DMD myotubes has a beneficial cell nonautonomous effect on myoblasts fusion. The gene discussed is SETDB1; the disease is Duchenne muscular dystrophy.